Changchun Institute of Biological Products: Application for clinical trials of modified Ankara smallpox vaccine attenuated live vaccine virus monkeypox vaccine has been accepted.

Chia Tai Bioannouncement, a wholly-owned subsidiary Anhui Chia Tai Longkomabio Pharmaceutical Co., Ltd. has been granted the acceptance notification for the application of clinical trials of the improved Ankara smallpox vaccine virus monkeypox attenuated live vaccine by the National Medical Products Administration. The acceptance number is CXSL2501083. Within 60 days from the date of acceptance, if there is no rejection or questioning from the Drug Evaluation Center, Chia Tai Longkomabio can proceed with the clinical trials according to the submitted plan.